Revenue up 17.5%, but profit growth stalls—the wage lock-in story

The gap between revenue and profit is the story of Q1. Subros grew sales 17.5% on strong auto industry momentum—passenger vehicle production +24%, Maruti +16.8%—but profit barely moved at 1.7%, and sequentially contracted 15.8%. The quarter lays bare a structural cost-pricing mismatch: wage inflation, commodity indexation lag, and e-compressor dilution are eroding margins faster than the company can recover them through customer pricing.

Haryana wages rose 30–32%; Uttar Pradesh 26–28%. These are structural hikes, not temporary labour market wobbles. Management initially downplayed them, but under analyst pressure in the Q&A—Mayur Parkeria from Wealth Managers pressed repeatedly—conceded they are structural and pass-through to customers is uncertain. No binding customer agreement is in place. Until it is, a 25–35% wage cost headwind will persist, compressing EBITDA by ~1% or more. This is the core risk to near-term profitability.

The company's prior 12% operating margin aspiration is now 'slightly pushed out'—management's euphemism for 'we don't know when.' No new target date was offered. Automation investment and productivity improvement are the hedges, but execution risk is high given competing capex needs (Kharkhoda, Karsanpura, e-compressor).

Denso/Toyota e-compressor partnership (August 2026): Signed. Subros will manufacture Denso's e-compressor for Maruti. Phased SOP November 2027–Q1 2028. Phase 1: 80–85% import content (low margin). Phase 2–3: localization to 55–70%. Margin recovery expected FY28–29 (3–4 year horizon). This is strategic—positions Subros for EV thermal leadership with a global OEM—but adds capex and dilutes near-term company margins. Revenue ramp begins late 2027; profit payoff lags until FY28–29.

Karsanpura Greenfield (Gujarat, early-stage): New facility for e-compressor and mechanical compressor. Supports EV/hybrid and ICE diversification. Increases capex complexity and debt burden alongside Kharkhoda ramp. Financial detail sparse; feasibility ongoing.

Kharkhoda on track: Phase 1+2 = 9.5 lakh capacity for Maruti North (Sonipat expansion). SOP Q3 FY27. Construction 'advanced stage,' machine readiness underway. This is execution-on-track, not a new strategic pivot.

Price action: The market's own verdict. Post-result on day 1: −6.1%. By day 3: −7.69%. By day 5: −8.5%. The decline held; no recovery bounce. This tells you the market sees the profit miss as structural, not cyclical. The ₹1,032 Cr revenue beat does not offset the margin story.

Valuation context: The stock is now ₹745.85, down 35.64% from its all-time high of ₹1,158.9. It sits below SMA20 (₹788.6), SMA50 (₹793.45), and SMA200 (₹802.15). A technical breakdown in progress. RSI 36.8 (neutral, approaching oversold). The stock is off its 52-week low (₹622.1) by 19.89%, but has further to fall if the wage-lock narrative persists through Q2–Q3.

Institutional flows: FII ownership at 32.69% (down 0.1pp QoQ), DII at 10.70% (down 0.07pp QoQ). Slight trim, not capitulation or aggressive buying into the drawdown. Promoters hold steady at 36.79%. No insider buying to signal confidence. June block deals (₹845–₹855 range) show broker flow, but no promoter or insider participation.